Moleculin Biotech (MBRX) Total Current Liabilities (2015 - 2026)
Moleculin Biotech (MBRX) recorded Total Current Liabilities of $9.31 million in Q2 2026, up 17.7% from $7.91 million a year earlier.
Powered by 
Analysis
Moleculin Biotech (MBRX) Total Current Liabilities (2015 - 2026) Analysis & Trends
At the end of FY2025, Moleculin Biotech reported Total Current Liabilities of $6.85 million, up 27.9% from FY2024.
- Annual Total Current Liabilities has a five-year compound annual growth rate of 18.6% (FY2020 to FY2025).
- Across earlier years, Total Current Liabilities came in at $5.36 million in FY2024 (-21.4%), $6.82 million in FY2023 (+41.4%), $4.82 million in FY2022 (+33.0%) and $3.62 million in FY2021 (+24.0%).
- The Q2 2026 figure is the highest quarterly Total Current Liabilities since Q3 2019.
- On a year-over-year basis, Total Current Liabilities rose in six of the last seven quarters, with growth averaging 19.3%.
- Peak year-over-year performance for Total Current Liabilities in the last five years was growth of 74.9% in Q2 2022, against a decline of 38.9% in Q3 2023 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,138.33 Bn | 1,106.91 Bn | 19.71 Bn | 47.74 Bn |
| 2 | Johnson & Johnson | 618.82 Bn | 537.35 Bn | 17.26 Bn | 54.90 Bn |
| 3 | AbbVie | 503.36 Bn | 476.47 Bn | 12.70 Bn | 41.64 Bn |
| 4 | Merck | 369.59 Bn | 323.96 Bn | 12.21 Bn | 27.73 Bn |
| 5 | Novartis Ag | 298.57 Bn | 262.56 Bn | 11.24 Bn | 31.75 Bn |
| 6 | Astrazeneca | 261.25 Bn | 234.94 Bn | 12.86 Bn | 31.55 Bn |
| 7 | Amgen | 237.35 Bn | 192.75 Bn | 7.24 Bn | 25.50 Bn |
| 8 | Gilead Sciences | 191.27 Bn | 165.47 Bn | 6.22 Bn | 11.02 Bn |
| 9 | Pfizer | 170.03 Bn | 116.68 Bn | 10.94 Bn | 32.65 Bn |
| 10 | Moleculin Biotech | 34.99 Mn | 4.59 Mn | - | 9.31 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.31 Mn |
| Dec 31, 2025 | 6.85 Mn |
| Sep 30, 2025 | 5.68 Mn |
| Jun 30, 2025 | 7.91 Mn |
| Mar 31, 2025 | 6.90 Mn |
| Dec 31, 2024 | 5.36 Mn |
| Sep 30, 2024 | 5.59 Mn |
| Jun 30, 2024 | 5.75 Mn |
| Mar 31, 2024 | 5.41 Mn |
| Dec 31, 2023 | 6.82 Mn |
| Sep 30, 2023 | 3.89 Mn |
| Jun 30, 2023 | 6.55 Mn |
| Mar 31, 2023 | 5.03 Mn |
| Dec 31, 2022 | 4.82 Mn |
| Sep 30, 2022 | 6.36 Mn |
| Jun 30, 2022 | 5.86 Mn |
| Mar 31, 2022 | 4.83 Mn |
| Dec 31, 2021 | 3.62 Mn |
| Sep 30, 2021 | 3.66 Mn |
| Jun 30, 2021 | 3.35 Mn |
API Access
Moleculin Biotech Total Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=MBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-current-liabilities", "ticker": "MBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=MBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();